MPAC conclusions and recommendations: October 2019

MPAC conclusions and recommendations: October 2019

On 2–4 October 2019, the World Health Organization (WHO) Malaria Policy Advisory Committee (MPAC) convened to review updates and progress, and provide guidance with respect to specific thematic areas of work carried out by the Global Malaria Programme (GMP).

The meeting included eight sessions focused on 14 topics: (1) an update on the “High burden to high impact” approach and the “One WHO Africa malaria programme”; (2) an update on the RTS,S Malaria Vaccine Implementation Programme; (3) an update from the Malaria Vaccine Advisory Committee; (4) the use of non-pharmaceutical forms of Artemisia; (5) an update on malaria elimination in the Greater Mekong Subregion; (6) an update on the Strategic Advisory Group on malaria eradication; (7) an update on the informal consultation to reconsider the formulation of malaria policy guidance; (8) a technical consultation to review the role of drugs in malaria prevention for people living in endemic settings; (9) an update on the technical consultation on malaria case management in the private sector in high-burden countries; (10) an update on the technical consultation on institutionalizing integrated community case management; (11) an update on the technical consultation on genomic surveillance; (12) an update on the technical consultation on Anopheles stephensi; (13) the revision of the WHO classification of glucose- 6-phosphate dehydrogenase variants and the International Classification of Diseases; and (14) an update on Malaria Elimination 2020 and STOP-Malaria.